|
MTRF1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68343117223912E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64612767861172E-12 |
| Normal-vs-Stage2 |
2.63759999996616E-06 |
| Normal-vs-Stage3 |
1.653650E-02 |
| Normal-vs-Stage4 |
2.035600E-01 |
| Stage1-vs-Stage2 |
9.493800E-01 |
| Stage1-vs-Stage3 |
9.076100E-02 |
| Stage1-vs-Stage4 |
4.088200E-02 |
| Stage2-vs-Stage3 |
1.553620E-01 |
| Stage2-vs-Stage4 |
8.347700E-02 |
| Stage3-vs-Stage4 |
6.891800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68653979670808E-12 |
| Normal-vs-AfricanAmerican |
3.88499999948166E-08 |
| Normal-vs-Asian |
1.379920E-02 |
| Caucasian-vs-AfricanAmerican |
4.911000E-01 |
| Caucasian-vs-Asian |
3.715000E-01 |
| AfricanAmerican-vs-Asian |
2.831200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62814206561279E-12 |
| Normal-vs-Female |
3.45000000012696E-07 |
| Male-vs-Female |
1.711500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.36559999869479E-08 |
| Normal-vs-Extreme_Weight |
1.63269398001376E-12 |
| Normal-vs-Obese |
5.68889999552624E-08 |
| Normal-vs-Extreme_Obese |
2.958300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.087600E-01 |
| Normal_Weight-vs-Obese |
4.383800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.291000E-01 |
| Extreme_Weight-vs-Obese |
1.303640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.673000E-01 |
| Obese-vs-Extreme_Obese |
8.526800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.012270E-02 |
| Normal-vs-Age(41-60Yrs) |
2.85570012081848E-10 |
| Normal-vs-Age(61-80Yrs) |
1.63125069008174E-12 |
| Normal-vs-Age(81-100Yrs) |
9.45750144865087E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.814600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.267900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.224100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.077700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.961760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63524749297039E-12 |
| Normal-VS-Type2 PRCC |
2.31300000264056E-08 |
| Normal-VS-KIRP CIMP |
5.909600E-01 |
| Normal-VS-Unclassified PRCC |
8.77439999991125E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.789200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.550800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.481000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.138400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.040400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.175610E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19529941500218E-11 |
| Normal-vs-N1 |
1.413600E-01 |
| Normal-vs-N2 |
1.54095000000076E-05 |
| N0-vs-N1 |
1.530030E-02 |
| N0-vs-N2 |
6.836200E-01 |
| N1-vs-N2 |
1.756180E-01 |
|
|
